395 filings
Page 4 of 20
8-K
kyzgld1
24 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3:56pm
8-K
cfrgj
2 Jun 22
Ampio Pharmaceuticals’ CEO Mike Martino Issues Letter to Stockholders
4:35pm
8-K
j981uex 5en
1 Jun 22
Departure of Directors or Certain Officers
4:00pm
8-K
tlfhc5kp0w81wca
16 May 22
Results of Operations and Financial Condition
12:00am
8-K
48s42pejsq9blt76h8
28 Apr 22
Conference Call Script
8:00am
8-K
m3ixech2dzdyv yod
20 Apr 22
Ampio Provides Regulatory Update
9:43pm
8-K
vmfh0e0vzyx3ukv2zr
29 Mar 22
Ampio Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Operational Highlights
4:17pm
8-K
8hgzowvi6o
2 Mar 22
Complete analysis of AP-013 data show Ampion reduced pain with statistical significance
4:38pm
8-K
eykz z0zgjk4
10 Feb 22
Entry into a Material Definitive Agreement
4:01pm
8-K
ixd3c8iyzbni3 b9n6
16 Dec 21
Regulation FD Disclosure
4:01pm
8-K
1ex1dkmir hposdm7
15 Dec 21
Entry into a Material Definitive Agreement
12:00am
424B5
kbkc1
14 Dec 21
Prospectus supplement for primary offering
5:06pm
8-K
d1vhf9 ldg
29 Nov 21
Departure of Directors or Certain Officers
4:01pm
8-K
md9yzktu8 xy6pvn
10 Nov 21
Further details to be discussed on this afternoon’s conference call
4:05pm
8-K
smg40l6ber9
15 Oct 21
Ampio Pharmaceuticals Strengthens Management Team and Board of Directors
9:15am